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ABSTRACT  
Objective: To estimate the underlying primary diseases of chronic renal failure (CRF) among patients attending Al-
Thawra General Hospital, Sana'a, and Yemen.  
Methods: This was a cross-sectional, hospital-based study of 566 patients diagnosed with chronic kidney diseases 
(CKD). It studied the cases attending Al-Thawra General Hospital over a three‐year period from January 2013 to De-
cember 2015.  
Results: Out of 566 patients, 339 (59.9%) were males. The mean age of the patients at diagnosis of CKD was 39.51 
years, most of whom (36.6%) were of the age group of 21–35 years. Hypertension was the most frequent cause 
(43.2%) of CRF, followed by different infectious diseases such as malaria, schistosomiasis and bacterial infections 
(19%) and obstructive nephropathy (17.9%). On the other hand, CRF of unknown etiology represented 15.2% of cas-
es. Other causes of CRF diabetic nephropathy (9.7%), effect of antibiotics and analgesics (7.0%), ischemic heart dis-
ease (4.8%, polycystic kidney disease (3.5%) and congenital anomalies (3.4%). The least common causes were auto-
immune diseases, bleeding, traumatic accidents and chronic diarrhea, being responsible for 2.2%, 1.8%, 0.9% and 
0.4% of CRF cases, respectively.  
Conclusions: The majority of CKD cases in our study were males aged between 21 and 35 years old. In addition, most 
cases of CKD are due to hypertension, followed by infections and obstructive nephropathy. Application of future pre-
vention and control measures are highly recommended to reduce the burden of CRF in Yemen for early detection and 
proper management of its underlying primary conditions/diseases. 
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1. Introduction 
Chronic kidney disease (CKD) is a major public 
health problem worldwide, including Yemen 
(1–2). Early referral of such diseases can help 
to preserve renal function and delay the pro-
gression of renal failure by managing their 
modifiable risk factors and treating secondary 
complications (3–6). CKD is defined according 
to the presence or absence of kidney damage 
and level of kidney function—regardless of the 
type of kidney disease (7). Its detection is based 
on simple biochemical tests such as a creati-
nine-based glomerular filtration rate (8), and it 
is categorized into five stages of increasing se-
verity (9). The frequency of cardiovascular dis-
ease (CVD), hypertension, diabetes and obesity 
is increasing throughout the world and is com-
monly associated with an increase in the preva-
lence of CKD (10–13). The increasing number of 
patients requiring dialysis and kidney replace-
ment therapy in Yemen poses challenges to 
health professionals and to the healthcare sys-
tem.  
Of 22 governorates in Yemen, Sana'a city is 
the capital and the most populated. A study on 
the end-stage renal disease (ESRD) in Sana'a 
(population 1,200,000) reported an incidence 
of 385 cases per million population/year (14). 
Moreover, the incidence of the ESRD is proba-
bly higher in the coastal city of Hodeidah due to 
the high prevalence of schistosomiasis and re-
nal stones. In the southern part of Yemen, about 
200 new cases per year are recorded in Aden 
(14). Development of CKD prevention and con-
trol strategies is a key factor for reducing the 
burden of the disease. In addition, exploring 
risk factors and at-risk populations are of par-
amount importance for developing suitable in-
terventions in different populations (15). 
Therefore, the aim of the present study was to 
estimate the underlying primary conditions of 
CRF in Al-Thawra General Hospital (AGH), 
Sana'a, Yemen. 
2. Methods 
2.1. Study design, ethical clearance and data 
collection 
This was a cross-sectional, hospital-based study 
carried out over a period of three years, from 
January 2013 to December 2015. The study pro-
tocol was approved by the Ethics Committee of 
the AGH and the Ethics Committee of the Faculty 
of Medicine and Health Sciences, University of 
Science and Technology. In addition, informed 
consent was obtained from study participants 
before data collection. It included 566 patients 
with CRF followed in the Nephrology Clinic and 
Dialysis Unit of the Urology and Nephrology 
Center, AGH. All patients in the present study 
fulfilled the revised National Kidney Foundation 
criteria for the diagnosis of CKD (1), excluding 
non-Yemenis and those with other life-
threatening diseases. The AGH is the largest 
public hospital in Yemen, which has the main di-
alysis center that receives patients from all 
around the country. Data about age and sex 
were collected using a data collection sheet. 
Clinical information on the underlying causes of 
CKD was obtained from patients' files.  
2.2. Statistical analysis 
The statistical analyses of the data were per-
formed by using SPSS Version 21.0 software. Pa-
tients' characteristics and the underlying prima-
ry causes of CKD were expressed as frequencies 
and percentages.  
3. Results 
Of 566 patients with CKD, 339 (59.9%) were 
males and 227 (40.1%) were females. The mean 
age of the patients was 39.51 years (range: 6–
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80), most of whom (36.6%) were in the age 
group of 21–35 years (Table 1). The underlying 
causes of CRF are summarized in Table (2). 
Among patients with CRF, hypertension 
(43.2%) was the most common cause, followed 
by infection (19.0%) and obstructive nephropa-
thy (17.9%) while CRF of unknown etiology 
represented 15.2% of cases. Other causes of 
CRF included diabetic nephropathy (9.7%), ef-
fect of antibiotics and analgesics (7.0%), is-
chemic heart disease (4.8%), polycystic kidney 
disease (3.5%) and congenital anomalies 
(3.4%). However, the least common causes of 
CRF were autoimmune diseases, bleeding, 
traumatic accidents and chronic diarrhea, being 
responsible for 2.2%, 1.8%, 0.9% and 0.4% of 
cases, respectively.  
Table 1. Distribution of chronic renal failure patients admitted to 
Al-Thawra General Hospital in Sana'a by their sex and age group 
(2013–2015) 
Age (years) 
Sex Total  
n (%) Male n (%) Female n (%) 
<20 29 (5.1) 27 (4.8) 56 (9.9) 
21–35 130 (23.0) 77 (13.6) 207 (36.6) 
36–50 89 (15.8) 76 (13.4) 165 (29.2) 
51–65 72 (12.7) 43 (7.6) 115 (20.3) 
66–80 19 (3.4) 4 (0.7) 23 (4.1) 
Total 339 (59.9) 227(40.1) 566 (100.0) 
4. Discussion 
CKD, also known as chronic renal disease, is a 
progressive kidney function loss that develops 
over months or years. In the present study, pa-
tients with CRF are predominantly males and 
are younger than those reported from other 
parts of the world (3–6, 10–13). The prevalence 
of hypertension as a cause of CRF in our study 
is higher than that reported from the developed 
countries, where hypertension as a cause of 
ESRF ranges from 24.5 to 30% (16). However, it 
is consistent with the rates previously reported 
from different areas and hospitals in Yemen, 
Table 2. Underlying causes of chronic renal failure among Yemeni 
patients admitted to Al-Thawra General Hospital in Sana'a (2013–
2015) 
Underlying cause 
Chronic renal failure n (%)   
Male Female Total 
Hypertension 142 (25.1) 102 (18.1) 244 (43.2) 
 
Infections 
 Malaria 21 (3.7) 7 (1.2) 28 (4.9)  
Chronic pyelonephritis 14 (2.4) 11 (2.0) 25 (4.4) 
Schistosomiasis 17 (3.0) 3 (0.5) 20 (3.5) 
Hepatitis B 16 (2.8) 6 (1.1) 22 (3.9) 
Hepatitis C 8 (1.3) 5 (1.0) 12 (2.3) 
Total 68 (13.2) 40 (5.8) 148 (26.1) 
Obstructive nephropathy 
 Stones 61 (10.8) 20 (3.5) 81 (14.3)  
Prostatic enlargement 1 (0.2) 0 (0.0) 1 (0.2) 
Neurogenic bladder 1 (0.2) 0 (0.0) 1 (0.2) 
Other causes of obstruction 12 (2.1) 6 (1.1) 18 (3.2) 
Total 75 (13.3) 26 (4.6) 101 (17.9) 
Unknown cause 43 (7.6) 43 (7.6) 86 (15.2) 
Diabetes 34 (6.0) 21 (3.7) 55 (9.7) 
Drug toxicity 
 Antibiotics 5 (1.0) 7 (1.2) 12 (2.2) 
Analgesics 16 (2.8) 11 (2.0) 27 (4.8) 
Total 21 (3.8) 18 (3.2) 39 (7.0) 
Ischemic heart disease 
 
18 (3.3) 9 (1.5) 27 (4.8) 
Polycystic kidney 
 
11 (2.0) 9 (1.5) 20 (3.5) 
Congenital anomalies 
 
12 (2.1) 7 (1.2) 19 (3.4) 
Autoimmune diseases 
 Systemic lupus erythematosus 2 (0.4) 4 (0.7) 6 (1.1) 
 Vasculitis 1 (0.2) 0 (0.0) 1 (0.2) 
 Post-streptococcal 2 (0.4) 3 (0.5) 5 (0.9) 
 Total 
 
5 (1.0) 7 (1.2) 12 (2.2) 
Bleeding 
 
3 (0.5) 7 (1.2) 10 (1.8) 
Traumatic accident  
 
3 (0.5) 2 (0.4) 5 (0.9) 
Chronic diarrhea 2 (0.4) 0 (0.0) 2 (0.4) 
 
where hypertension was the most common 
cause of CRF (17–20). It is noteworthy that hy-
pertension is also an important risk factor for 
CVDs and can influence their high incidence 
among CKD patients (10–13). 
Infections, including malaria, chronic pyelo-
nephritis, hepatitis B and C and schistosomiasis, 
were the second most common cause of CRF 
among Yemeni patients. This is in contrast to the 
developed countries, where infections are the 
least common causes of CRF (21); however, it is 
consistent with findings reported from Jordan, 
Egypt, North Africa, Pakistan and India, where 
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infections such as glomerulonephritis are 
common causes of CRF (22–27). On the other 
hand, Obstructive nephropathy was the third 
most common primary cause (17.9%) of CRF 
among Yemeni patients, which is mainly caused 
by urolithiasis. Similarly, previous studies re-
ported that obstructive neuropathy was report-
ed to cause 13.5–17.1% of CRF among Yemeni 
patients (17–20). However, a slightly lower rate 
of 11.0% of CRF secondary to obstructive neu-
ropathy was reported from Egypt (26). 
The low rate of less than 10% of CRF sec-
ondary to diabetes in the present study is lower 
than those reported from neighboring coun-
tries, where higher rates of CRF (17.0–43.0%) 
were attributed to diabetes (5, 22, 28, 29,30). 
Diabetes is also an important risk factor for 
CVDs, influencing their high incidence among 
CKD patients (10–13). Furthermore, 15.2% of 
CRF among Yemeni patients in the present 
study was attributed to unknown etiology. This 
is much lower than that reported in previous 
studies from Yemen, where unknown etiology 
accounted for 57.0% of CRF (19, 20). Such a 
relatively high rate of CRF of unknown etiology 
might be attributed to delayed medical counsel-
ing until failure already happened or to the 
shortage of diagnostic tools. In addition, the 
rate of CRF of unknown etiology in the present 
study is lower than those reported from Egypt 
and Turkey, being 27.0 and 26.7%, respectively 
(31, 32). 
Polycystic kidney disease was the most 
common congenital disease causing CRF, being 
responsible for 3.5% of cases in the present 
study, whereas other congenital diseases collec-
tively represented 3.4% of the causes. In previ-
ous studies in Yemen, polycystic kidney disease 
accounted for 6.6 and 2.5% of CRF causes in 
Sana'a city and Hajjah governorate, respectively 
(17, 19, 20). The finding of the present study is 
inconsistent with that reported from Turkey, 
where congenital diseases caused 8.9% of CRF 
(32). In the present era, drugs have emerged as 
important causes of renal injury and CRF. In this 
context, antibiotics and analgesics accounted for 
4.8 and 2.2% of CRF among Yemeni patients, re-
spectively. However, a slightly higher rate of 
6.0% was reported from Egypt (31). The rate of 
other causes of CRF in the present study is simi-
lar to those reported elsewhere from both the 
developed and developing countries (16, 21, 
32), where ischemic heart disease and autoim-
mune diseases, mainly systemic lupus erythema-
tosus were responsible for 4.8 and 1.1% of cas-
es, respectively. The least common causes of 
CRF in the present study were associated with 
bleeding (1.8%), accidental trauma (0.9%) and 
chronic diarrhea (0.4%). This finding is similar 
to those reported elsewhere (16, 21, 33). 
5. Conclusions 
CRF is a major public health problem in Yemen 
that has great socioeconomic and medical con-
sequences. The majority of CKD cases in our 
study were males, aged between 21 and 35 
years old. In addition, most cases of CKD are due 
to hypertension, followed by infections and ob-
structive nephropathy. The incidence of CKD is 
expected to increase in Yemen as the population 
ages and the prevalence of infections, diabetes 
and hypertension rises; however, many people 
are unaware they have reduced kidney function. 
Earlier identification of CKD accompanied by 
aggressive treatment consisting of well-known 
therapies holds the potential to slow progres-
sion to kidney failure and prevent development 
of sequelae, including CVDs and premature 
death. Consideration of the co-morbid condi-
tions associated with CKD, including hyperten-
sion, diabetes, infections, CVDs, and anemia, is 
essential for optimal patient management and 
slowing of CKD progression as well as for careful 
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use of healthcare cost. Improving the manage-
ment of patients with CKD requires education 
and action by all facets of the healthcare sys-
tem, including patients, physicians and re-
searchers. 
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